Cidara Therapeutics
CDTX
CDTX
66 hedge funds and large institutions have $76.2M invested in Cidara Therapeutics in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 3.05% → 3.11% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
18% less capital invested
Capital invested by funds: $92.7M → $76.2M (-$16.5M)
Holders
66
Holding in Top 10
4
Calls
$154K
Puts
$58K
Top Buyers
| 1 | +$2.71M | |
| 2 | +$761K | |
| 3 | +$418K | |
| 4 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$359K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$349K |
Top Sellers
| 1 | -$720K | |
| 2 | -$471K | |
| 3 | -$323K | |
| 4 |
Jane Street
New York
|
-$130K |
| 5 |
Two Sigma Advisers
New York
|
-$103K |